Navigation Links
Effectiveness Of Drug-Releasing Coronary Stents

A new study appearing in the February 22 issue of the Journal of American Medical Association has found no significant differences in the effectiveness of the coronary stents coated with either sirolimus or paclitaxel. Drug-releasing stents are known to be more effective in easing the examination of the blood vessels in a procedure called as angiography. //

Such stents also improve the prognosis or the outcome of procedures like angioplasty, when a catheter-guided balloon is used to widen a narrow coronary artery. But it was not clear as to which drug is more useful in these procedures. A team of reserachers led by Marie-Claude Morice, M.D., of the Institut Cardiovasculaire Paris Sud, Massy, France compared the efficacy of the two drugs, which were used to coat stents in patients with new coronary artery lesions. The trial called REALITY examined 1,386 patients with angina pectoris in 90 hospitals in Europe, Latin America, and Asia between August 2003 and February 2004. The patients were randomly assigned either a sirolimus-releasing stent or paclitaxel-releasing stent. It was found that the incidence of narrowing of coronary artery was 9.6 percent in the former and 11.1 percent in the latter. “A longer follow-up may be required for the different degrees of neointimal [a new layer of cells on the inner surface] proliferation suppression to translate into significantly different rates of binary restenosis or adverse clinical events,” the authors suggested.
'"/>




Page: 1

Related medicine news :

1. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
2. The Effectiveness Of Screening Tests Questioned
3. The Effectiveness Of Chickenpox Vaccine Questioned
4. The Effectiveness Of Antibacterial Products In Reducing Infection
5. The Effectiveness Of Cancer Drug In Women At Risk Of Developing Cancer
6. The Effectiveness Of The Breast Cancer Drug By Pfizer
7. Effectiveness Of Prostate Cancer Test
8. Studying The Effectiveness Of Cough Syrups
9. The Effectiveness Of NSAIDs Evaluated
10. Effectiveness Of Infertility Treatments Questioned
11. Report on the Safety and Effectiveness of Melatonin supplements
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/28/2017)... ... February 28, 2017 , ... BrightStar Care Marietta announced that it has received ... Pulse. This award is granted only to top-ranking home care providers, based on client ... ranked among home care providers from across the country who have proven their ability ...
(Date:2/27/2017)... (PRWEB) , ... February 27, 2017 , ... ... mass and overall body strength, which often leads to a host of health ... Journal of the American Geriatrics Society discovered that good overall muscle strength ...
(Date:2/27/2017)... (PRWEB) , ... February 27, 2017 , ... Much attention ... concern for women who become dependent on opioid painkillers has fallen short. From 1999 ... compared to a 237% increase in fatal overdoses in male populations.(1) , The proportion ...
(Date:2/27/2017)... ... February 27, 2017 , ... This webinar , sponsored ... a tool to characterize particle size distributions in the field of geoscience and ... novel scientific findings. It describes methods of optimized and standardized sample collection, preparation ...
(Date:2/27/2017)... Vancouver, BC (PRWEB) , ... February 27, 2017 ... ... top drug rehabilitation and alcohol treatment programs in British Columbia, Canada, at ... (RMT) to its team. The new hire, Mackenzie Alsager, showcases the Centre's commitment ...
Breaking Medicine News(10 mins):
(Date:2/28/2017)... FRANCISCO , February 28, 2017 The global  pulse ... a new report by Grand View Research, Inc. The pulse oximeters market is ... to the growing prevalence of target diseases such as chronic obstructive pulmonary disease ... Continue Reading ... Grand View Research ...
(Date:2/28/2017)... , Feb 28, 2017 Nordic Nanovector ASA (OSE: ... 2016. A presentation of the results by the company,s senior management ... Oslo - details below. ... 2016 was a very successful year for ... development of Betalutin®, progressed with our preclinical candidates and build the ...
(Date:2/27/2017)... Ga., Feb. 27, 2017 Halyard Health, Inc. (NYSE: ... 2016 results and provided its 2017 outlook and related key ... sales were $410 million, a 2 percent increase compared to ... fourth quarter 2016 was $10 million compared to net income ... quarter adjusted net income was $24 million compared to adjusted ...
Breaking Medicine Technology: